Authors:
WOODS KL
KETLEY D
AGUSTI A
HAGN C
KALA R
KARATZAS NB
LEIZOROWICZ A
REIKVAM A
SCHILLING J
SEABRAGOMES R
VASILIAUSKAS D
WILHELMSEN L
Citation: Kl. Woods et al., USE OF CORONARY ANGIOGRAPHY AND REVASCULARIZATION PROCEDURES FOLLOWING ACUTE MYOCARDIAL-INFARCTION - A EUROPEAN PERSPECTIVE, European heart journal, 19(9), 1998, pp. 1348-1354
Authors:
WOODS KL
KETLEY D
LOWY A
AGUSTI A
HAGN C
KALA R
KARATZAS NB
LEIZOROWICZ A
REIKVAM A
SCHILLING J
SEABRAGOMES R
VASILIAUSKAS D
WILHELMSEN L
Citation: Kl. Woods et al., BETA-BLOCKERS AND ANTITHROMBOTIC TREATMENT FOR SECONDARY PREVENTION AFTER ACUTE MYOCARDIAL-INFARCTION - TOWARDS AN UNDERSTANDING OF FACTORSINFLUENCING CLINICAL-PRACTICE, European heart journal, 19(1), 1998, pp. 74-79
Authors:
WOODS KL
KETLEY D
AGUSTI A
HAGN C
KALA R
KARATZAS NB
LEIZOROVICZ A
LOWY A
REIKVAM A
SCHILLING J
GOMES RS
VASILIAUSKAS D
WILHELMSEN L
Citation: Kl. Woods et al., TRANSLATION OF CLINICAL-TRIALS INTO PRACTICE - A EUROPEAN POPULATION-BASED STUDY OF THE USE OF THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION, Lancet, 347(9010), 1996, pp. 1203-1207
Authors:
COLLINS R
PETO R
FLATHER M
PARISH S
SLEIGHT P
CONWAY M
PIPILIS A
BAIGENT C
BARNETT D
BOISSEL JP
BUDAJ A
CAIRNS J
CEREMUZYNSKI L
COHEN AF
DEBACKER G
DIAZ R
DIENSTL F
DOVE P
FRANZOSI MG
GENONI M
HALON DA
HEIKKILA J
HENNEKENS C
HORGAN J
HUNT D
KALA R
KARATZAS N
KEECH A
KELTAI M
KJEKSHUS J
KORNITZER M
KOSTER R
LANDLESS P
LECHLEITNER P
LEIZOROVICZ A
LEWIS BS
LUNDKVIST L
MACMAHON S
MAGGIONI A
MALACRIDA R
MEYER T
MOCCETTI T
OCALLAGHAN D
PAOLASSO E
PIEGAS LS
REIKVAM A
RIDKER P
RYAN T
SCHRODER R
SEABRAGOMES R
SOUSA JEMR
TOGNONI G
TURPIE A
VALENTIN V
VARIGOS J
WHITE H
WILHELMSEN L
WOODS K
YUSUF S
PIOMBO A
GUZMAN LA
MONTENEGRO DC
IRUSTA G
SCHNEIDER RA
CUNEO C
CHAMORRO BH
ESPINOSA GE
MORENO M
RIOS MM
DOLL R
FOX K
JULIAN D
MEIER P
SANDOYA E
PEREZ JE
Citation: R. Collins et al., ISIS-4 - A RANDOMIZED FACTORIAL TRIAL ASSESSING EARLY ORAL CAPTOPRIL,ORAL MONONITRATE, AND INTRAVENOUS MAGNESIUM-SULFATE IN 58,050 PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION, Lancet, 345(8951), 1995, pp. 669-685
Authors:
APPLEBY P
BAIGENT C
COLLINS R
FLATHER M
PARISH S
PETO R
BELL P
HALLS H
MEAD G
DIAZ R
PAOLASSO E
PAVIOTTI C
ROMERO G
CAMPBELL T
OROURKE MF
THOMPSON P
LESAFFRE E
VANDEWERF F
VERSTRAETE M
ARMSTRONG PW
CAIRNS JA
MORAN C
TURPIE AG
YUSUF S
GRANDE P
HEIKKILA J
KALA R
BASSAND JP
BOISSEL JP
BROCHIER M
LEIZOROVICZ A
BRUGGEMANN T
KARSCH KR
KASPER W
LAMMERTS D
NEUHAUS KL
MEYER J
SCHRODER R
VONESSEN R
SARAN RK
ARDISSINO D
BONADUCE D
BRUNELLI C
CERNIGLIARO C
FORESTI A
FRANZOSI MG
GUIDUCCI D
MAGGIONI A
MAGNANI B
MATTIOLI G
ROSSI P
SAONTRO E
TOGNONI G
VISANI L
ZENNARO RG
KANEMOTO N
KAWAI C
ARNOLD AER
BAR FW
SIMOONS ML
VERHEUGT FWA
VERMEER F
WHITE HD
SEABRAGOMES R
FIGUERAS J
LOPEZSENDON J
GRIP L
HERLITZ J
KARLSSON JE
WALLENTIN L
MONNIER P
ADAMS PC
BEEN M
CHAMBERLAIN DA
DEBONO D
DOLL R
DUFF D
FOX KAA
SREEHARAN N
HILLIS WS
JULIAN DG
MALCOLM A
MURRAY RG
PATTERSON DLH
POCOCK S
REID DS
SANDERCOCK P
SIGWART U
SKELDING J
SKENE A
SLEIGHT P
TIMMIS A
WARLOW C
WILCOX RG
ALLEN A
ANDERSON J
BRAUNWALD E
CALIFF R
GOLD HK
GRANETT J
GRAINGER C
GUERCI AD
HENNEKENS C
HONAN MB
KENNEDY JW
KNATTERUD G
LEE K
LEIMBERGER J
LENERT LA
LITTLEJOHN J
MAYNARD C
NICKLAS J
OHMAN M
OLSON HG
PASSAMANI E
RYAN TJ
SELKER HP
STUMP D
TOPOL EJ
WEAVER WD
WILLIAMS DO
WOODLIEF L
Citation: P. Appleby et al., INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS, Lancet, 343(8893), 1994, pp. 311-322
Citation: T. Krusius et al., SHORT-TERM ASPIRIN TREATMENT DOES NOT REDUCE PLASMA-FIBRINOGEN CONCENTRATION IN YOUNG HEALTHY-ADULTS, Thrombosis research, 75(6), 1994, pp. 653-656
Citation: Sp. Gupta et al., RESPONSE OF SULFUR TO SOME KHARIF CROPS GROWN IN COARSE-TEXTURED SOILS OF HARYANA, Annals of Arid Zone, 32(4), 1993, pp. 255-256
Authors:
HUNT D
VARIGOS J
DIENSTL F
LECHLEITNER P
DEBACKER G
KORNITZER M
CAIRNS J
TURPIE A
FRITZHANSEN P
SKAGEN K
KALA R
HEIKKILA J
BOISSEL JP
LEIZOROVICZ A
SCHRODER R
KOTHE K
KARATZAS N
HORGAN J
OCALLAGHAN D
TOGNONI G
FRANZOSI MG
MAGGIONI A
COHEN A
KOSTER R
WHITE H
MACMAHON S
KJEKSHUS J
REIKVAM A
CEREMUZYNSKI L
PAOLASSO E
DIAZ R
VALENTIN V
WILHELMSEN L
LUNDKVIST L
MOCCETTI T
MALACRIDA R
GENONI M
COLLINS R
SLEIGHT P
PETO R
PARISH S
DOLL R
ARMITAGE P
CEDERHOLMWILLIAMS S
CONWAY M
DOVE P
FLATHER M
MARSHALL J
YOUNGMAN L
JULIAN D
CHAMBERLAIN D
WARLOW C
SANDERCOCK P
FOX K
HENNEKENS C
GOLDHABER S
TIMMIS G
YUSUF S
MEIER P
Citation: D. Hunt et al., ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION, Lancet, 339(8796), 1992, pp. 753-770